The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 147.00
Bid: 140.50
Ask: 145.00
Change: 0.00 (0.00%)
Spread: 4.50 (3.203%)
Open: 147.00
High: 0.00
Low: 0.00
Prev. Close: 147.00
XAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

26 Aug 2016 11:44

RNS Number : 2674I
Xaar PLC
26 August 2016
 

Xaar plc (the "Company")

Grant of Options

The Company announces that on 25 August 2016 the following Executive Directors of the Company were granted share options over ordinary shares of 10 pence each in the Company ("Ordinary Shares") under the terms of the 2007 Long Term Incentive Plan ("LTIP"), as follows:

Name

Role

Percentage of salary options granted at market value

No. of options* granted over Ordinary Shares

Total no. of options** held post grant

Doug Edwards

Chief Executive Officer

75%

47,559

198,213

Alex Bevis

Chief Financial Officer

50%

19,562

205,812

* Options granted on 25 August 2016 under the LTIP scheme.

** Options granted under all schemes.

This grant is made in order to position total remuneration in line with relevant comparable companies for our CEO and CFO and is made following approval of Resolution 15 at the Annual General Meeting on 18 May 2016, which approved the proposed amendment to the Xaar plc 2007 LTIP rules to increase the limit on the market value of the shares that may be granted under a performance share award to an employee from 100% to 175% of base salary in such financial year.

This grant was approved by the Remuneration Committee on 17 August 2016. The delay in approving the grant since the AGM was as a result of status of discussions on the acquisition of Engineered Printing Solutions as announced on 1 July 2016 and Xaar's close period.

No consideration was paid for the grant of any of the options, or is due on the exercise of options granted under the LTIP scheme. These options carry certain specific performance criteria which must be achieved prior to vesting, which is 3 years after the date of grant, when the options are ordinarily exercisable. The options will expire on the tenth anniversary of the date of grant.

Enquiries:

Xaar plc

Alex Bevis - Chief Financial Officer

+44 (0) 1223 423 663

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFSITVIRFIR
Date   Source Headline
3rd Sep 20201:20 pmRNSNotice of Interim Results
1st Sep 202010:42 amRNSTotal Voting Rights
5th Aug 202012:47 pmRNSTotal Voting Rights
3rd Aug 20208:59 amRNSChange of Adviser
16th Jul 20207:00 amRNSTrading Statement
9th Jul 20204:36 pmRNSPrice Monitoring Extension
1st Jul 20203:17 pmRNSConfirmation of Board Change & Succession
1st Jul 202011:47 amRNSTotal Voting Rights
5th Jun 20207:00 amRNSGrant of Options
2nd Jun 202011:16 amRNSTotal Voting Rights
2nd Jun 202011:13 amRNSResult of AGM
2nd Jun 20207:00 amRNSTrading Statement
15th May 202010:59 amRNSHolding(s) in Company
7th May 20207:00 amRNSNotice of Annual General Meeting
1st May 20203:10 pmRNSTotal Voting Rights
30th Apr 20202:27 pmRNSHolding(s) in Company
29th Apr 202012:04 pmRNSDisclosure of Rights attached to Equity Shares
29th Apr 202011:41 amRNSGrant of option
28th Apr 20205:27 pmRNSHolding(s) in Company
27th Apr 20202:23 pmRNSHolding(s) in Company
27th Apr 20202:00 pmRNSDirectorate Change - Appointment
24th Apr 20203:10 pmRNSHolding(s) in Company
24th Apr 20203:02 pmRNSAnnual Financial Report
23rd Apr 20202:35 pmRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSAnnual Financial Report
9th Apr 20209:15 amRNSHolding(s) in Company
6th Apr 20203:35 pmRNSHolding(s) in Company
1st Apr 20202:49 pmRNSTotal Voting Rights
1st Apr 20207:00 amRNSConfirmation of Board Changes and Succession
23rd Mar 20205:47 pmRNSTrading Statement-COVID-19 & Preliminary Statement
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 20208:41 amRNSHolding(s) in Company
2nd Mar 202011:38 amRNSTotal Voting Rights
25th Feb 20207:41 amRNSHolding(s) in Company
18th Feb 20201:04 pmRNSHolding(s) in Company
13th Feb 20204:57 pmRNSHolding(s) in Company
12th Feb 20205:25 pmRNSHolding(s) in Company
3rd Feb 202012:41 pmRNSTotal Voting Rights
16th Jan 20207:00 amRNSTrading Statement
9th Jan 20207:00 amRNSDirectorate Change
8th Jan 202011:09 amRNSHolding(s) in Company
3rd Jan 20203:32 pmRNSBlock listing Interim Review
2nd Jan 20202:15 pmRNSTotal Voting Rights
10th Dec 20193:51 pmRNSHolding(s) in Company
4th Dec 20194:53 pmRNSCompletion of Investment by Stratasys in Xaar 3D
2nd Dec 20195:39 pmRNSTotal Voting Rights
27th Nov 201910:35 amRNSResult of General Meeting
19th Nov 20199:23 amRNSHolding(s) in Company
18th Nov 20193:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.